Your browser doesn't support javascript.
loading
Risk factors for hemorrhage in patients with long-term aspirin therapy undergoing emergency external ventricular drainage/intracranial pressure probe placement.
Gao, Fei; Ge, Shunnan; Cui, Wenxing; Zhao, Jingya; Yang, Yang; Guo, Wei; Bai, Hao; Wang, Bao; Yang, Chen; Mu, Shijie; Wang, Liang; Zhao, Tianzhi; Qu, Yan; Cai, Yaning.
Afiliação
  • Gao F; Department of Neurosurgery, Tangdu Hospital, Xi'an, China.
  • Ge S; Department of Neurosurgery, The 986 Hospital of PLAAF, Xi'an, China.
  • Cui W; Department of Neurosurgery, Tangdu Hospital, Xi'an, China.
  • Zhao J; Department of Neurosurgery, Tangdu Hospital, Xi'an, China.
  • Yang Y; Department of Blood Transfusion, Tangdu Hospital, Xi'an, China.
  • Guo W; Department of Emergency, Tangdu Hospital, Xi'an, China.
  • Bai H; Department of Neurosurgery, Tangdu Hospital, Xi'an, China.
  • Wang B; Department of Neurosurgery, Tangdu Hospital, Xi'an, China.
  • Yang C; Department of Neurosurgery, Tangdu Hospital, Xi'an, China.
  • Mu S; Department of Neurosurgery, Tangdu Hospital, Xi'an, China.
  • Wang L; Department of Blood Transfusion, Tangdu Hospital, Xi'an, China.
  • Zhao T; Department of Neurosurgery, Tangdu Hospital, Xi'an, China.
  • Qu Y; Department of Neurosurgery, Tangdu Hospital, Xi'an, China.
  • Cai Y; Department of Neurosurgery, Tangdu Hospital, Xi'an, China.
Heliyon ; 10(5): e26854, 2024 Mar 15.
Article em En | MEDLINE | ID: mdl-38463769
ABSTRACT

Background:

Studies have been inconclusive on the risk for hemorrhage in patients with a history of aspirin use who underwent emergency external ventricular drainage (EVD)/intracranial pressure (ICP) probe placement. The aim of this study was to explore hemorrhage-related risk factors in order to reduce the risk for hemorrhage in these patients.

Methods:

Between July 2014 and July 2020, patients were retrospectively divided into EVD/ICP-related hemorrhage and non-hemorrhage groups. The collected data included age, gender, major diagnosis, medical history, imaging examinations, conventional coagulation test data, thromboelastography with platelet mapping (TEG-PM), surgical procedures and discharge conditions.

Results:

In total 94 patients, 21 in the hemorrhage group (15 males, 6 females) and 73 in the non-hemorrhage group (52 males, 21 females) were included. The majority of hemorrhages were recorded in EVD patients (19/21; 90.5%). Platelet AA pathway inhibition rate of ≥75% (sensitivity 79.45% specificity 52.38%) (P = 0.014) and SBP ≥125 mmHg (P = 0.006) were significantly related to hemorrhage. When the platelet AA pathway inhibition rate was ≥75% and the during-procedure SBP was ≥125 mmHg, the hemorrhage rate was significantly higher (83.3%) than with SBP <125 mmHg (6.7%) (P < 0.001). When the inhibition rate was <75%, there were no significant differences in the hemorrhage rates between the during-procedure SBP ≥125 mmHg group (17.2%) and the SBP <125 mmHg group (13.2%) (P > 0.05). Multivariate logistic regression analysis revealed that a platelet AA pathway inhibition rate ≥75% (OR = 5.183, 95% CI 1.683-15.960) and during-procedure SBP ≥125 mmHg (OR = 4.609, 95% CI 1.466-14.484) were independent risk factors for EVD/ICP-related hemorrhage.

Conclusion:

Patients with long-term aspirin therapy, a platelet AA pathway inhibition rate ≥75% and during-procedure SBP ≥125 mmHg had a significantly higher risk of hemorrhage, which could be reduced by adjusting the SBP to <125 mmHg.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article